{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:59:11Z","timestamp":1722992351311},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"Supplement_E","license":[{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":71,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Brugada syndrome (BrS) has been often described as a purely electrical disease. However, current dogma surrounding this concept has shifted to accept that BrS is associated with structural abnormalities. Brugada syndrome is now associated with epicardial surface and interstitial fibrosis, reduced gap junction expression, increased collagen, and reduced contractility. The ventricular arrhythmias observed in BrS have been linked to an arrhythmogenic substrate (AS) located rather consistently in the right ventricular outflow tract, sparking much debate as to the significance of this anatomical position. The size of the AS is dynamic and can be altered due to a number of factors. A larger AS is associated with reduced contractility, and this impaired mechanical function may be responsible for syncopal episodes in BrS patients in the absence of arrhythmic events. While BrS is generally regarded as a channelopathy, recent studies have now identified also mutations in genes encoding for sarcomeric proteins to be associated with BrS. Future studies should evaluate electromechanical coupling in BrS, including calcium handling and sarcomeric alterations, and evaluate whether BrS should be classified as a cardiomyopathy.<\/jats:p>","DOI":"10.1093\/eurheartj\/suaa071","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T09:12:30Z","timestamp":1591261950000},"page":"E101-E104","source":"Crossref","is-referenced-by-count":10,"title":["Right ventricular electromechanical abnormalities in Brugada syndrome: is this a cardiomyopathy?"],"prefix":"10.1093","volume":"22","author":[{"given":"Carlo","family":"Pappone","sequence":"first","affiliation":[{"name":"Arrhythmology and Electrophysiology Department, IRCCS Policlinico San Donato, San Donato Milanese, Milano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M","family":"Monasky","sequence":"first","affiliation":[{"name":"Arrhythmology and Electrophysiology Department, IRCCS Policlinico San Donato, San Donato Milanese, Milano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Micaglio","sequence":"first","affiliation":[{"name":"Arrhythmology and Electrophysiology Department, IRCCS Policlinico San Donato, San Donato Milanese, Milano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Ciconte","sequence":"first","affiliation":[{"name":"Arrhythmology and Electrophysiology Department, IRCCS Policlinico San Donato, San Donato Milanese, Milano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,3,25]]},"reference":[{"key":"2020060405102000400_suaa071-B1","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3389\/fphys.2018.01088","article-title":"Calcium in Brugada syndrome: questions for future research","volume":"9","author":"Monasky","year":"2018","journal-title":"Front Physiol"},{"key":"2020060405102000400_suaa071-B2","doi-asserted-by":"crossref","first-page":"e005053.","DOI":"10.1161\/CIRCEP.117.005053","article-title":"Electrical substrate elimination in 135 consecutive patients with Brugada syndrome","volume":"10","author":"Pappone","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2020060405102000400_suaa071-B3","author":"Pappone","year":"2018"},{"key":"2020060405102000400_suaa071-B4","doi-asserted-by":"crossref","DOI":"10.1097\/PEC.0000000000001640","article-title":"Seizures, Meds, and Vtach: a journey to a Brugada diagnosis","author":"Fitzgerald","year":"2018","journal-title":"Pediatr Emerg Care"},{"key":"2020060405102000400_suaa071-B5","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/eurheartj\/ehp252","article-title":"Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities","volume":"30","author":"Catalano","year":"2009","journal-title":"Eur Heart J"},{"key":"2020060405102000400_suaa071-B6","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/europace\/euv300","article-title":"Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters","volume":"18","author":"Rudic","year":"2016","journal-title":"Europace"},{"key":"2020060405102000400_suaa071-B7","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.hrthm.2010.09.004","article-title":"Spontaneous type 1 electrocardiographic pattern is associated with cardiovascular magnetic resonance imaging changes in Brugada syndrome","volume":"7","author":"Papavassiliu","year":"2010","journal-title":"Heart Rhythm"},{"key":"2020060405102000400_suaa071-B8","doi-asserted-by":"crossref","first-page":"e42037.","DOI":"10.1371\/journal.pone.0042037","article-title":"SCN5A mutations in Brugada syndrome are associated with increased cardiac dimensions and reduced contractility","volume":"7","author":"van Hoorn","year":"2012","journal-title":"PLoS One"},{"key":"2020060405102000400_suaa071-B9","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1161\/CIRCRESAHA.116.305017","article-title":"Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death","volume":"116","author":"Abriel","year":"2015","journal-title":"Circ Res"},{"key":"2020060405102000400_suaa071-B10","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2010.09.084","article-title":"SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism","volume":"57","author":"McNair","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2020060405102000400_suaa071-B11","doi-asserted-by":"crossref","first-page":"11303.","DOI":"10.1038\/ncomms11303","article-title":"A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillation","volume":"7","author":"Orr","year":"2016","journal-title":"Nat Commun"},{"key":"2020060405102000400_suaa071-B12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/dvg.22400","article-title":"Proliferation of embryonic cardiomyocytes in zebrafish requires the sodium channel scn5Lab","volume":"51","author":"Bennett","year":"2013","journal-title":"Genesis"},{"key":"2020060405102000400_suaa071-B13","doi-asserted-by":"crossref","first-page":"385.","DOI":"10.3389\/fneur.2018.00385","article-title":"Flecainide-induced Brugada syndrome in a patient with skeletal muscle sodium channelopathy: a case report with critical therapeutical implications and review of the literature","volume":"9","author":"Cavalli","year":"2018","journal-title":"Front Neurol"},{"key":"2020060405102000400_suaa071-B14","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/01.CIR.0000118467.53182.D1","article-title":"Delay in right ventricular activation contributes to Brugada syndrome","volume":"109","author":"Tukkie","year":"2004","journal-title":"Circulation"},{"key":"2020060405102000400_suaa071-B15","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.bbamcr.2016.02.014","article-title":"The role of mutations in the SCN5A gene in cardiomyopathies","volume":"1863","author":"Zaklyazminskaya","year":"2016","journal-title":"Biochim Biophys Acta"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/22\/Supplement_E\/E101\/33342566\/suaa071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/22\/Supplement_E\/E101\/33342566\/suaa071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T09:12:35Z","timestamp":1591261955000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/22\/Supplement_E\/E101\/5851028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,25]]},"references-count":15,"journal-issue":{"issue":"Supplement_E","published-online":{"date-parts":[[2020,3,25]]},"published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/suaa071","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6]]},"published":{"date-parts":[[2020,3,25]]}}}